AMIDEX35 Israel Fund Class A (AMDAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Miscellaneous region
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund will invest at least 95% of its net assets in the common stocks of the companies comprising the AMIDEX35™ Index, in approximately the same percentages as those companies are included in the index or until the fund's net assets reach $25 million, the Adviser may invest fund assets in a representative sample of index securities and other permissible securities. The AMIDEX35™ Index is an unmanaged index consisting of the 35 largest publicly traded Israeli companies, as measured by market capitalization. It is non-diversified.


1 month+3.83% 3 years+5.40%
3 months+1.43% 5 years-0.52%
1 year+0.53% Since inception+0.98%
Data through --

Peer Comparisonvs. Miscellaneous region

Performance 5-yr return-0.52%+3.00%
Expense ratio3.37%1.93%
Risk 5 year sharpe ratio0.020.30
Net assets$12.6M$248.7M
Average market cap$5.7B$22.7B
Average P/E16.714.4
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAMIDEX
Fund manager & tenureGadi Beer / 11 Years
Minimal initial investment$500.00
Minimum IRA investment$500.00


International stock76.73%
U.S. stock22.26%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 27.12%
Healthcare 24.31%
Telecommunication 13.32%
Consumer goods 4.11%
Hardware 2.63%
Top 10 Holdings
Portfolio weighting
TEVA Teva Pharmaceutical11.85%
CHKP Check Point Software Technologies Ltd8.14%
ICL ICL Israel Chemicals Ltd7.84%
PRGO Perrigo Company PLC6.66%
-- 5.11%
DOX Amdocs Ltd4.95%
TARO Taro Pharmaceutical Industries Ltd4.44%
-- 4.21%
IRLCF Israel Corporation Ltd3.78%
PAY VeriFone Systems Inc3.05%

To view my watchlist

Not a member yet?

Sign up now for a free account